The Effect of Core and Coating Composition on Drug Release from Directly Compressed Time-Controlled Release Tablets - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Effect of Core and Coating Composition on Drug Release from Directly Compressed Time-Controlled Release Tablets
The authors prepared and tested press-coated tablets with various weight ratios of ethylcellulose to hydroxypropylcellulose (HPC) and various ratios of two different batches of HPC as an outer coating shell and fillers in core tablets. The tablets were examined for changes in time lag and release patterns of salbutamol sulfate.


Pharmaceutical Technology


References

1. T. Bussemer, I. Otto, and R. Bodmeier, "Pulsatile Drug Delivery Systems," Crit. Rev. Ther. Drug Carrier Syst. 18 (5), 433–458 (2001).

2. B.C. Youan, "Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery?" J. Controlled Release 98, 337–353 (2004).

3. B. Lemmer, "Why Are So Many Biological Systems Periodic?" Proceedings of the APV Course: Pulsatile Drug Delivery-Current Applications and Future Trends, 20–22 (1992).

4. E.R. Sutherland and H.S. Nalson, "Nocturnal Asthma," J. Allergy Clin. Immunol. 1179–1186 (2005).

5. S.Y. Lin, K.H. Lin, and M.J. Li, "Micronized Ethylcellulose Used for Designing a Directly Compressed Time-Controlled Disintegration Tablet," J. Controlled Release, 70, 321–328 (2001).

6. S.Y. Lin, M.J. Li, and K.H. Lin, "Formulation Design of Double-layer in the Outer Shell of Dry-coated Tablet to Modulate Lag Time and Time-Controlled Dissolution Function: Studies on Micronized Ethylcellulose for Dosage Form Design (VII),"AAPS J. 6 (3), Article 17 (2004).

7. S.Y. Lin, M.J. Li, and K.H. Lin, "Hydrophilic Excipients Modulate the Time Lag of Time-Controlled Disintegrating Press-Coated Tablets," AAPS PharmSciTech. 5 (4), Article 54 (2004).

8. E. Fukui, K. Uemura, and M. Kobayashi, "Studies on Applicability of Press-Coated Tablets using Hydroxypropylcellulose (HPC) in the Outer Shell for Timed-Release Preparations." J. Controlled Release 68, 215–223 (2003).

9. D.S. Roy and B.D. Rohera, "Comparative Evaluation of Rate of Hydration and Matrix Erosion of HEC and HPC and Study of Drug Release from Their Matrices," Eur. J. Pharm.Sci. 16, 193–199 (2002).

10. K. Hauschild and K.M. Picker, "Evaluation of a New Coprocessed based on Lactose and Maize Starch for Tablet Formulation" AAPS PharmSci. 6 (2), article 16 (2004).

11. G.S. Rekhi and S.S. Jambhekar, "Ethylcellulose-A Polymer Review," Drug. Devlop. Ind. Phrm. 21 (1), 66–77 (1995).

12. U. Conte et al., "Press-coated Tablets for Time Programmed Release of Drugs." Biomaterials 14 (13), 1017–1023 (1993).


ADVERTISEMENT

RELATED CONTENT
Roche Recalls Viracept
Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium
The Effect of Core and Coating Composition on Drug Release from Directly Compressed Time-Controlled Release Tablets
Near-Infrared Assay and Content Uniformity of Tablets
Maintain Your Moving Parts
blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here